Dermal fillers, particularly the hyaluronic acid type used in most cosmetic clinics, carry real long-term risks that go beyond the temporary bruising and swelling your injector likely mentioned. While millions of people get fillers without serious problems, the FDA has stated plainly that “the safety of these products used repeatedly over a long period of time has not been evaluated in a controlled, clinical study.” That gap in evidence matters, especially as newer imaging technology reveals that fillers behave differently inside the body than many patients are told.
Fillers Don’t Dissolve the Way You Think
The standard sales pitch for hyaluronic acid fillers is that they naturally break down in 6 to 12 months. MRI imaging tells a different story. Oculoplastic surgeon Kami Parsa recently shared 3D MRI scans of a 33-year-old woman who had received a total of 12 ccs of filler over six years. When his team measured the actual volume of filler still present in her face, it came to roughly 28 ccs, more than double what had been injected. Hyaluronic acid is hydrophilic, meaning it attracts and holds water, which causes it to expand in tissue rather than quietly metabolize away.
This doesn’t happen to every patient, but it challenges the reassuring idea that filler simply disappears on schedule. For people who get regular touch-ups assuming the previous round is gone, the cumulative volume in their face may be far greater than they realize.
Filler Migration Is Common in Certain Areas
Filler doesn’t always stay where it’s placed. A narrative review published in the journal Cosmetics found that injections into the nose, lips, nasolabial folds, and forehead are the most frequent sites of migration. Tear trough injections (the hollows under your eyes) carry a specific risk of filler migrating into the orbit.
Several forces push filler out of position over time. Gravity pulls it downward. Repeated muscle contractions, like those from frowning or smiling, can shift product that was placed near active muscles. Filler injected into the nasolabial folds can gradually drift toward the chin crease through a combination of gravity and muscular movement. In the forehead, product can migrate through connective tissue layers toward the eye socket. Even massage or external pressure on the face can displace filler from its original location.
Poor injection technique makes migration worse, but even well-placed filler is subject to the mechanical forces of a face that moves thousands of times a day.
Bone Loss Under Deep Filler
One of the more alarming findings in recent years involves bone resorption, where the bone beneath deep filler injections actually erodes. The FDA has identified up to 60 cases in published literature of bone loss in the chin, jaw, midface, or forehead following supraperiosteal injections (filler placed directly on top of the bone). All reported cases involved hyaluronic acid fillers specifically.
Patients in these cases had no symptoms. The bone loss was discovered incidentally on CT scans or dental X-rays taken for unrelated reasons. Because this complication is silent, it’s unclear how many people are affected but haven’t been scanned. The FDA now recommends against injecting filler into bone, tendon, ligament, or muscle.
Biofilms and Chronic Inflammation
Bacteria can colonize filler material and form biofilms, which are structured bacterial communities encased in a protective matrix that shields them from your immune system. This happens when a needle passes through skin during injection and carries resident bacteria into the deeper tissue where the filler sits. Once a biofilm establishes itself on filler material, it can persist for months or years.
The practical result is recurrent, unexplained swelling or nodules that flare up long after the initial injection. These episodes can be triggered by illness, dental work, or anything that activates the immune system. The biofilm bacteria reduce their growth rate and evade the body’s infection-fighting cells, making them resistant to standard antibiotic treatment. Histological samples from these cases show high concentrations of bacteria in and around the filler, with severe inflammatory cell reactions. The filler itself may degrade more slowly in the presence of a biofilm, prolonging the cycle of symptoms.
Delayed Nodules and Granulomas
Between 0.6 and 0.8 percent of patients develop hypersensitivity reactions, including nodules, after hyaluronic acid filler injections. That may sound small, but given that millions of filler procedures are performed annually, it represents a significant number of people. Foreign body granulomas, a more serious form of chronic inflammation where the body walls off material it can’t break down, occur in an estimated 0.01 to 1 percent of cases. These can appear months or even years after injection, well past the point when most patients have stopped associating new symptoms with their filler.
Permanent fillers carry substantially higher risks. Silicone and similar non-resorbable materials persist indefinitely in tissue, and the longer a foreign material stays in the body, the higher the chance of granuloma formation. Treating a granuloma that contains a permanent filler is especially difficult and can cause significant damage to surrounding tissue.
Lymphatic Obstruction and Chronic Swelling
Filler can physically obstruct the tiny lymphatic vessels responsible for draining fluid from your face. This is particularly problematic in the under-eye area. One retrospective study found that nearly 25 percent of patients developed prolonged swelling (malar edema) after hyaluronic acid injections in the tear trough, lasting an average of 5.4 months. For some patients, this puffiness becomes a persistent issue that looks worse than the original concern they were trying to treat.
The “Filler Fatigue” Question
You may have heard the term “filler fatigue,” the idea that repeated injections stretch out facial skin over time, leaving it looser and more aged-looking once filler wears off. The honest answer is that no controlled clinical study has directly tested this. It’s difficult to separate the effects of repeated filler from normal age-related loss of collagen and elastin, which happens to everyone. What is clear from MRI evidence is that filler can expand to more than double its injected volume through water absorption, which does stretch surrounding tissue. Whether that stretching causes permanent laxity remains unproven but biologically plausible.
What Happens If You Dissolve Filler
Hyaluronic acid fillers can be dissolved with an enzyme called hyaluronidase, which is a genuine advantage over permanent fillers. The catch is that hyaluronidase breaks down both the injected filler and some of your body’s own naturally occurring hyaluronic acid in the treated area. This is why people often notice temporary hollowing or flatness right after dissolution.
The good news is that this effect is localized and temporary. Your body begins regenerating its natural hyaluronic acid within two to four weeks, and levels typically return to normal within one to three months. The cells responsible for producing hyaluronic acid (fibroblasts) are not damaged by the enzyme, so your skin’s regenerative capacity stays intact. Dissolving filler won’t leave you permanently worse off than your baseline, though it may take a few months to see your true face again.
Areas the FDA Warns Against
The FDA specifically recommends against using dermal fillers in several locations: between the eyebrows (glabella), the nose, around the eyes, the forehead, and the neck. These are all areas where filler is routinely injected at cosmetic clinics despite the agency’s caution. The FDA also warns against filler for breast augmentation, buttock enhancement, and foot injections. Injectable silicone is not approved for any aesthetic procedure and has been linked to long-term pain, infections, permanent disfigurement, blood vessel blockages, stroke, and death.
Side effects from filler can appear weeks, months, or years after injection, and permanent fillers may be difficult or impossible to remove once complications develop.